Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.54 is 16300% below its 5-year average of 0.00, near the low end of its 5-year range (-0.55–0.56).
3.85% below its 12-month average of -0.52.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:45:12.121Z. Historical observations retain their original dates. Historical series through 2023-05-04.
EARNINGS PER SHARE (EPS)
-0.54
EARNINGS PER SHARE (EPS) AVG TTM
-0.52
EARNINGS PER SHARE (EPS) AVG 3Y
-0.25
EARNINGS PER SHARE (EPS) AVG 5Y
0.00
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.85%
CURRENT VS 3Y AVG
-118.18%
CURRENT VS 5Y AVG
-16300.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
AbCellera Biologics Inc.
Market Cap
$4.21B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.52
3Y Avg
-0.25
5Y Avg
0.00
Market Cap
$4.34B
Earnings Per Share (EPS)
-1.85
TTM Avg
-1.54
3Y Avg
-1.48
5Y Avg
-1.19
Market Cap
$4.03B
Earnings Per Share (EPS)
1.18
TTM Avg
-2.40
3Y Avg
-2.29
5Y Avg
-0.02
Market Cap
$4.50B
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.45
3Y Avg
-1.45
5Y Avg
-1.45
Market Cap
$4.78B
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.74
3Y Avg
-1.01
5Y Avg
-1.11
Market Cap
$3.62B
Earnings Per Share (EPS)
-1.94
TTM Avg
-2.32
3Y Avg
-2.00
5Y Avg
-1.79
Market Cap
$4.81B
Earnings Per Share (EPS)
-3.43
TTM Avg
-1.80
3Y Avg
-1.89
5Y Avg
-2.15
Market Cap
$3.59B
Earnings Per Share (EPS)
-4.29
TTM Avg
-3.30
3Y Avg
-2.99
5Y Avg
-2.52
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $4.21B | -0.54 | -0.52 | -0.25 | 0.00 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.34B | -1.85 | -1.54 | -1.48 | -1.19 |
| ICU Medical, Inc. (ICUI)vs › | $4.03B | 1.18 | -2.40 | -2.29 | -0.02 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | -1.42 | -1.45 | -1.45 | -1.45 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | -0.41 | -0.74 | -1.01 | -1.11 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.62B | -1.94 | -2.32 | -2.00 | -1.79 |
| CareDx, Inc (CDNA)vs › | $3.61B | 2.07 | 0.30 | -1.10 | -0.90 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | -3.43 | -1.80 | -1.89 | -2.15 |
| Celcuity Inc. (CELC)vs › | $3.59B | -4.29 | -3.30 | -2.99 | -2.52 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | -0.13 | -3.38 | -5.70 | -8.99 |
Trailing EPS (TTM)
$-0.54
Forward EPS (Est.)
$-0.66
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.49 |
| 2024-12-31 | -0.55 |
| 2023-12-31 | -0.51 |
| 2022-12-31 | 0.56 |
| 2021-12-31 | 0.56 |
| 2020-12-31 | 0.45 |
| 2019-12-31 | -0.01 |
| 2018-12-31 | 0.00 |
